CDT Equity CEO-linked entity acquires CDT shares
CDT Equity Inc. director and CEO Dr. Regan reported indirect purchases and conversions through affiliated entities.
Rhea-AI Filing Summary
CDT Equity Inc. director and CEO Dr. Regan reported indirect purchases and conversions through affiliated entities. On March 24, 2026, Corvus Capital Limited, which he controls, exercised all its pre-funded warrants via cashless exercise into 147,401 shares of Common Stock, eliminating the warrant position. On May 13, 2026, Corvus bought an additional 100,000 shares in the open market at $1.90 per share for total cash consideration of $190,000, bringing Corvus’s reported Common Stock holdings to 256,393 shares. Separate indirect holdings via Manoira Corporation total 773 shares, and Dr. Regan also holds 5,600 shares directly. All share amounts reflect a 1‑for‑25 reverse stock split effected on March 26, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 100,000 | $1.90 | $190K |
| Conversion | Pre-Funded Warrants | 147,401 | $0.0001 | $14.74 |
| Grant/Award | Common Stock | 147,401 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (7)
- F1. On March 26, 2026, CDT Equity Inc. (the "Company") effected a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Corvus ceased to be a 10% holder as of February 19, 2026.
- F2. On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.
- F3. These shares of Common Stock are owned of record by Corvus.
- F4. On May 13, 2026, Corvus purchased a total of 100,000 shares of Common Stock in the open market at a price per share of $1.90 for total cash consideration of $190,000.
- F5. These shares of Common Stock are owned of record by Manoira Corporation ("Manoira").
- F6. Corvus is the owner of 99.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.
- F7. The Pre-Funded Warrants have been exercised in full.
Key Figures
Key Terms
reverse stock split financial
Pre-Funded Warrants financial
cashless exercise financial
beneficially own financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported for CDT (CDT Equity Inc.) on this Form 4?
What happened to the pre-funded warrants reported in the CDT Form 4?
What are CEO Dr. Regan’s reported CDT holdings after these transactions?
Were the CDT insider transactions open-market trades or awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.